Hologic Cash Flow Statement
HOLX / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 15 fiscal years. All figures from audited SEC 10-K filings.
Hologic generated $1.1B in operating cash flow and $998M in free cash flow in FY2025. Free cash flow margin was 24.3% of revenue.
Based on SEC 10-K filings.
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $565.7M | $789.5M | $456.0M | $1.3B | $1.9B | $1.1B | -$203.6M | -$111.3M | $755.5M | $330.8M | $131.6M | $17.3M | -$1.2B | -$73.6M | $157.2M |
| Operating Cash Flow | $1.1B | $1.3B | $1.1B | $2.1B | $2.3B | $896.6M | $649.5M | $732.9M | $8.3M | $798.2M | $796.8M | $508.4M | $493.8M | $370.2M | $456.0M |
| Capital Expenditures | $58.8M | $72.4M | $91.8M | $70.6M | $118.3M | $98.3M | $57.0M | $58.4M | $57.8M | $47.3M | $48.1M | $44.3M | $49.0M | $33.1M | $27.8M |
| Free Cash Flow | $998.3M | $1.2B | $959.4M | $2.1B | $2.2B | $798.3M | $592.5M | $674.5M | -$49.5M | $750.9M | $748.7M | $464.1M | $444.8M | $337.1M | $428.2M |
| Share Buybacks | $752.9M | $835.1M | $474.8M | $542.1M | $409.8M | $653.6M | $200.1M | $275.8M | $200.1M | $250.0M | $0 | $0 | - | - | - |
| FCF Margin | 24.3% | 30.1% | 23.8% | 42.3% | 39.3% | 21.1% | 17.6% | 21.0% | -1.6% | 26.5% | 27.7% | 18.3% | 17.8% | 16.8% | 23.9% |